Wikisage, the free encyclopedia of the second generation, is digital heritage

Aspirin: Difference between revisions

From Wikisage
Jump to navigation Jump to search
No edit summary
 
(17 intermediate revisions by the same user not shown)
Line 1: Line 1:
Aspirin is an AINE
Aspirin is an [[Non-steroidal antiinflammatory drug| NSAID]]
<ref>https://karmel.miraheze.org/wiki/PenaRC2/profilaxis_AAS</ref>
<ref>https://karmel.miraheze.org/wiki/PenaRC2/profilaxis_AAS</ref>
A recommendation of AAs-clopidogrel to maintain the patency of the stent following coronary intervention. Clopidogrel is a P2Y12 inhibig platelet agent; the combination AAs Ticagrelor wasn´t better than clopidogrel+aspirin
A recommendation of AAs-[[clopidogrel]] to maintain the patency of the stent following coronary intervention. Clopidogrel is a P2Y12 inhibiting platelet agent; the combination AAs Ticagrelor wasn´t better than clopidogrel+aspirin
<ref>https://www.mdpi.com/2077-0383/8/1/104/htm Clopidogrel versus Ticagrelor for Secondary Prevention after Coronary Artery Bypass Grafting]</ref>
<ref>[https://www.mdpi.com/2077-0383/8/1/104/htm Clopidogrel versus Ticagrelor for Secondary Prevention after Coronary Artery Bypass Grafting]</ref>
==Kawasaki==
[[File:Kawasaki_tongue_1.jpg|thumb]]
==[[Kawasaki disease|Kawasaki]]==
 
Protocols recommend AAs and intravenous immunoglubin; however many cases have be shown to be refractory  to this treatment
<ref>[http://www.e-mjm.org/2018/v73n6/refractory-kawasaki-disease.pdf A case report of refractory kawasaki disease]</ref>
<ref>[http://www.e-mjm.org/2018/v73n6/refractory-kawasaki-disease.pdf A case report of refractory kawasaki disease]</ref>
==[[Hutchinson-Gilford Progeria]]==
[[File:Progeri n1.jpg|thumb]]
Low dosis Aspirin 2-3 mg/Kg body weight is recommended for prevention of cardiovascular and stroke complications
<ref>[https://www.ncbi.nlm.nih.gov/pubmed/20301300 Hutchinson-Gilford Progeria Syndrome]</ref>
==[[ATC]]==
[[File:Under construction icon.png|thumb|left]]
[[File:Aspirin-B-3D-balls.png|thumb]]
Salicylic acid and derivates
*Acetylsalicylic acid (INN)
[https://www.whocc.no/atc_ddd_index/?code=N02BA01  N02BA01]
==Links==
==Links==
[https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-019-3872-0 Level and variation on quality of care in China: a cross-sectional study for the acute myocardial infarction patients in tertiary hospitals in Beijing]
[https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-019-3872-0 Level and variation on quality of care in China: a cross-sectional study for the acute myocardial infarction patients in tertiary hospitals in Beijing]
Line 10: Line 27:
<references/>
<references/>


 
[[nl:aspirine]]
{{Wikidata|Q}}
{{Wikidata|Q18216}}
[[Category:World Health Organization essential medicines]]

Latest revision as of 01:36, 26 January 2019

Aspirin is an NSAID [1] A recommendation of AAs-clopidogrel to maintain the patency of the stent following coronary intervention. Clopidogrel is a P2Y12 inhibiting platelet agent; the combination AAs Ticagrelor wasn´t better than clopidogrel+aspirin [2]

Kawasaki

Protocols recommend AAs and intravenous immunoglubin; however many cases have be shown to be refractory to this treatment [3]

Hutchinson-Gilford Progeria

Low dosis Aspirin 2-3 mg/Kg body weight is recommended for prevention of cardiovascular and stroke complications [4]

ATC

Salicylic acid and derivates

  • Acetylsalicylic acid (INN)

N02BA01

Links

Level and variation on quality of care in China: a cross-sectional study for the acute myocardial infarction patients in tertiary hospitals in Beijing

Q18216 at Wikidata  Interwiki via Wikidata